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D!TRODUCTION 
With the great expansion of blood banking facilities and the avail-
ability of a relatively safe form of colloidal iron for intravenous 
administration, large amounts of iron are administered directly into 
the blood stream in the treatment of a large,variety of anemias. The 
increasing incidence of systemic hemosiderosis after repeated blood 
transfusions and the prolonged oral administration of iron in anemic 
patients calls for certain precautions to avoid the possible tissue 
damage resulting from prolonged use of blood transfusion and intravenous 
injection of iron. Recently the syndrome of extensive systemic hemo-
siderosis with cirrhosis of liver in anemic patients who have received 
repeated blood transfusions or iron administra~on has been recognized 
as "exogenous hemochromatosis11 in order to differentiate it from idio-
pathic hemochromatosis which is a rare disease of unknown etiology and 
is characterized by excessive hemosiderin pigmentation of the skin and 
viscera with associated fibrosis of the involved viscera. 
The clinical and pathological findings of most of the reported cases 
of exogenous hemochromatosis strongly suggest that extensive deposition 
of iron is capable of inducing functional and morphological damage in 
the liver, spleen or pancreas resulting in cirrhosis and diabetes 
mellitus. The similarity of certain clinical and pthological changes 
between exogenous and idiopathic hemochromatosis has led to the thought 
that these two conditions may differ from each other quantitatively 
rather than qualitatively (11) and that the excessive absorption or 
storage of iron might be the chief etiological factor of idiopathic 
hemochromatosis. However, this concept is still highly controversial 
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and there is still much disagreement as to the etiologic role of the 
iron stores in the production of tissue damage. Furthermore the 
experimental evidence in support of such a theory is still lacking. The 
present status of the controversy is evidenced by the following three 
theories: 
(A) The excessive absorption and storage of iron in the liver is 
the primary event giving rise to hepatic damage and consequent cirrhosis 
(32, 51, 60, 90). In addition to the occurrence o£ hepatic fibrosis 
following multiple blood transfusions and prolonged iron administration 
(9, 75, 85, 94, 98 1 123, 143), this view is further supported by the 
£act that the deposition of iron usually precedes the fibrosis even in 
idiopathic hemoohromatosis (6, 10, 51, 72, 77, 125, 142, 146). Moreover 
repeated phlebotomies with depletion o£ iron deposits have been noted to 
effect clinical improvement and amelioration o£ the cirrhosis on repeated 
liver biopsies in patients with idiopathic hemochromatosis (6, 21, 22, 71, 
111, 136). On the other hand, this view is not favored by the absence o£ 
cirrhosis in oases o£ intense hemosiderosis in congenital hematoporphyrin-
uria (121), in pernicious anemia with multiple blood transfusion (74, 145) 
and in animal experiments producing an overloading o£ iron (~, 13, 93 1 104, 
115). 
(B) Cirrhosis is the primary disorder and hemosiderosis is merely a 
secondary phenomenon (79, 97, 121). MUir and Dunn (95, 96) stated 
"the fibrosis comes first certainly in the liver, because in many places 
in this disease (idiopathic hemochromatosis), there are abundant deposits 
o£ iron without signs o£ irritation and in ordinary cirrhosis the liver 
may contain more iron than usual." Roth (120) in 1915 stated that the 
increase o£ connective tissue was due to some derangement of liver £unction 
and not to the deposition of pigment. However, there is little evidence to 
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support this point of view save for the failure to observe cirrhosis in . 
certain instances of marked hemosiderosis. 
(c) The hemosiderosis and cirrhosis are two separate processes 6 
caused by unknown primary disturbances which independently give rise to 
the abnormalities of iron metabolism and functianal as well as structural 
changes in the liver~ pancreas and other organs (26, 60). Sheldon (125) 
suggested that the two processes of pigmentation and cirrhosis were 
independent effects of a single cause, probably an inborn error of 
metabolism. He added, however, that when the pigmentation has reached a 
certain degree or intensity, it may by irritation accelerate the develop-
ment of new fibrous tissue. Aufderheide (5) and Wyatt (73, 143, 144) and 
their associates suggested that the cirrhosis develops independently due 
to a local nutritional deficit, in which the intensity of the cirrhosis 
may depend upon the duration and severity of the anemia and not solely 
upon the excessive passage of altered hemoglobin or excessive iron intp 
liver cells. The frequent occurrence of exogenous hemochromatosis in 
anemic patients also suggested that anemia might be an additional factor 
in the develmpment of exogenous hemochromatosis. Herbut and his associates 
(65, 66), by reviewing necropsied oases and animal experiments, concluded 
that ttin hemochromatosis, the cirrhosis and diabetes maybe caused by a 
single substance, a ureide, and the cirrhosis further aggravated by 
dietary deficiencies and hyper-cholesterolemia." The hemosiderosis, he 
proposed, merely represented a separate disturbance following an abnormal 
retention of iron derived exogenously and perhaps to some extent 
endogenously. 
No one of the above theories is well substantiated. 1fuch attention 
has been directed, therefore to experimental studies aimed at establishing 
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the possible role of iron overload in the production of tissue damage. 
These expe~iments are summarized in Table l and will be reviewed later. 
As can be seen~ no conclusive decision has been reached and further 
studies are indicated. 
In the belief that the inconclusive experimental results may have 
been due to the use of inadequate amounts of iron as well as to insufficient 
periods of observation, the present experiment of prolonged intravenous 
administration of large amounts of iron was undertaken to answer the 
follavdng questions: 
(l) What is the pattern of progressive experimental iron overload in 
rabbits? 
(2) Will prolonged and intensive administration of iron progress from 
simple iron pigmentation of tissues to structural changes such as cirrhosis? 
(3) Is the amount of iron deposit or the duration the more important 
factor in the development of cirrhosis? 
(4) Is anemia an additional factor in the development of tissue damage 
in iron overloading? 
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REVIEW OF LITERATURE 
The effect of prolonged administration o£ iron can be best understood 
against a background of the normal metabolism of iron. Therefore~ the 
literature is reviewed with respect to iron metabolism in the normal state 
and in conditions associated with the excessive storage of iron in the 
hope o£ clarifying some of the problems o£ iron overload. 
I. Iron metabolism in the normal state. 
Iron is one o£ the indispensable minerals in human metabolism. It is 
a component of hemoglobin as well as o£ such oxidizing enzymes as the 
cytochromes, catalase and peroxidase. Its insignificant total amount of 
3-5 gm. in the human body is quite out of proportion to its great 
importance. About 55% of the total amount o£ iron in the human body is 
found in hemoglobin~ and about lQ% in muscle hemoglobin and heme enzymes; 
the remainder - some 3Q% to 35% - constitute the storage iron fraction, 
the major portion of which (some 0.8 gm.) is found in the liver, spleen 
and red bone marrow~ largely in the form of non-heme iron compounds and 
ferritin~ an iron protein complex (61). The human body handles iron 
very economically, using it over and over again; only a small amount (1-1.5 
mg) is found in the bile, sweat and excreta each day (23, 28, 51, 82 1 91, 
106, 139, 140), as was confirmed by tracer studies with radioactive iron 
by Copp and Greenberg (l?), Hahn et al (55) and Dubach et al (25). This 
small excretion cannot be appreciably increased by loading the body with 
iron by oral ingestion, by parenteral administration or by multiple blood 
transfusions (49, 54). The amount of iron in the body is mainly regulated 
by control of its absorption rather than by excretion. The regulation of 
iron absorption is in some way dependent upon the body needs of iron. 
5 
Iron is absorbed from the gastrointestinal tract in ferrous form. 
Owing to gastric acid and reducing agents such as -SH group of proteins 
and ascorbic acid in the food supply, the ferric iron of foodstuff is 
changed to ferrous iron before absorption. The ferrous iron is absorbed 
in the mucosal cells of the duodenum and jejunum and some of it combines 
with apoferritin to for.m ferritin (146, 48, 50). The mechanism of regula~ 
tion of iron absorption in the gastrointestinal tract was recently suggested 
by Granick (51) and many other investigators as follows: 
(1) MUcosal cells provide a one-way transfer of ferrous iron into 
these cells. Once iron gets into the organism it can no longer get out. 
Widdonson and McCance (139) demonstrated in 1937 that iron injected into 
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the blood stream in larger dose was not excreted by way of the urine or feces. 
(2) Normally, there is a resistance or mucosal block to iron 
absorption. Anemia can increase the absorption of iron into the blood 
stream. Hahn and Whipple (54, 58) have demonstrated this in dogs with 
radio-active iron as a tracer. Relatively little radioactive iron fed 
to a normal dog is absorbed, but a chronically anemic dog will absorb 
5 to 20 times the amount absorbed by the normal dog~ Dubach et al (24) 
demonstrated that patients with fever, untreated pernicious anemia and 
refractory anemia absorbed more radioactive iron than they used for 
hemoglobin and patients with hemolytic anemia may absorb more iron than 
can be recovered in the peripheral blood at any o:ne time because isotopic 
hemoglobin is removed from circulation at a rapid rate_. The absorbed 
iron is only used for erythropoiesis in anemia; once the demands of 
. the bone marrow are met_, the absorption stops (32),. 
(3) There is a relationship between this resistance or mucosal block 
and the storage of iron. Hahn (57) demonstrated that it is the depletion 
of iron stores and not the anemia itself that stimulates iron deposition. 
When a well-nourished dog is bled of 6Q% of its blood volume and then fed 
iron$ no more iron is absorbed than before hemorrhage; whereas after a 
week has elapsed, that is, after depletion of iron stores might be expected 
to have occurred, the absorption is increased. Granick (51) thought not 
only that the ferritin (the storage form of iron) was depleted in the 
liver, spleen and marrow, but also that the ferritin in the mucosal cells 
of the gastrointestinal tract was broken down. 
(4) The presance of ferritin is in some way connected with the 
presence of mucosal block; only when ferritin in the mucosal cells is 
depleted can more ferrous iron be absorbed. That the level of ferritin 
in mucosal cells readily responds to the feeding of iron has been 
demonstrated in guinea pigs (51). In this animal ferritin is normally 
present only in traces in the mucosa. When high doses of ferrous iron 
are fad, ferritin is found to increase, especially in the duodenal 
region, and then after a few days to decrease. 
The amount of iron absorbed is regulated by the amount of ferrous 
iron that the mucosal calls will tolerate. Ferrous iron passes from the 
intestinal lumen into the mucosal cells in one direction (51). Once 
the iron enters the cell, it never passes back again through the cell 
membrane. The ferrous iron of the mucosal cell is considered to be in 
equilibrium with the ferritin of these cells and with the plasma iron 
of the blood stream, governed in part by the oxidation-reduction potential 
of these cells. When iron absorption is active, the ferritin concentra-
tion of intestinal mucosal cells increases to a high concentration, and 
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further absorption of iron is blocked. The ferrous iron leaves the 
mucosa and proceeds to the blood strewm where the oxygen tension is such 
as to auto-oxidize the ferrous iron to ferric iron. This ferric oxide 
becomes attached to the metal-combining globulin (Fraction IV-7) and is 
transported to the tissues of the body as a complex of ferric-hydroxide~ 
protein. If plasma iron is lowered because of various conditions, the 
mucosal cells are depleted of their iron which then permits increased 
absorption of iron from the gastrointestinal tract. The plasma iron~ 
-in turn is in equilibrium with the ferrous iron and ferritin of the 
liver~ spleen and bone marrow# and here, too, rapid exhhanges of iron 
are possible (47, 56, 134). When in unusual situations, the rate or 
the quantity of iron deposition is too great to be handled by the 
ferritin mechanism, hemosiderin is formed in the tissues (136, 52). 
In the bone marrow~ not only is ferrous iron converted to ferritin, 
but also ferrous iron is incorporated into protoporphyrin to form heme 
which then combines with globin to form hemoglobin (31). This hemoglobin 
iron is constantly reutilized. 
Degenerated red cells are destroyed by the phagocytes of the liver~ 
spleen and bone marrow. This breakdown still leaves the iron intact~ and 
this iron is again used by the body to build up hemoglobin and its various 
other iron compounds. Therefore the daily requirement of 5 mg iron is 
adequate for the human body even for the period of most rapid growth. 
Under normal conditions, the excretion and absorption of iron are very 
small in wmount. Normally, a maximum of about 1.5 mg of iron per day is 
mg 
absorbed.f and about 1.0/or less is lost. The net gain of o.5 mg per day 
is enough to make possible manufacture of 300 - 600 oc of blood per year. 
·II. S~udies in iron storage diseases (hemochromatosis) 
1. Idiopathic Hemochromatosis 
Idiopathic hemochromatosis usually occurs in males past middle age 
with an occasional hereditary influence (125). It is characterized by 
excessive hemosiderin deposition in the skin and viscera, with associated 
fibrosis of some organs, particularly the liver and pancreas. The 
clinical and morphological features of this disease have been well known 
for a long time, but the knowledge of its pathogenesis is still far from 
clear. The following etiological factors, none of which are convincing, 
have been suggested: Inborn error in cellular metabolism; a disorder of 
metabolism of iron in the cytochrome system; some inability to utilize 
certain iron compounds; abnormally increased iron absorption in the 
intestinal tract over a long period owing to some congenital defect.in 
the mucosal block; exogenous poisons or metallic poisons such as alcohol, 
copper, lead and zinc; protein lack in nutrition, infectious disease 
(hepatitis) and reduction of pancreatic secretion (64). There is still 
a good deal of controversy on this point. The clinical and experimental 
investigations of this disease can be summarized as follows: 
(A) Clinical investigations 
(1) Incidence of hemochromatosis: Hemochromatosis is rare in 
females, but when present, it occurs in the post-menopausal age. It has 
been suggested that its rarity in younger women is explained by the fact 
that they have menstruation and pregnancy as a means of excreting iron, 
mechanisms not present in the male. Houston (71) stated that during the 
30 years of reproductive life of the female, the average loss of iron 
through menstruation and pregnancy is probably about 10-15 gm. In a 
9 
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woman with the underlying metabolic defect of hemochromatosisJ this loss. 
might be sufficient to delay or suppress the clinical expression of the 
disease. His study of the age incidence of hemochromatosis lent some support 
to this hypothesis. In Sheldon's series (125) 277 cases in males were 
fairly evenly spread on each side of the peak incidence at 45-50 years. 
Only 2 of his 14 oases in females occurred before this age. According 
to Houston (7l),Sheldon later stated that 1 of his 2 young females did 
not have proven hemochromatosis and was included in his chart of the age 
incidence by error; hence of his 13 female patients, only 1 developed the 
disease before the menopause. Houston himself further investigated the 
age incidence in 202 cases in males and 20 in females collected from the 
literature after 1935 and found only 2 females under 45 years of age. 
It was particularly interesting that 1 of the 2 young females had had 
amenorrhea for 13 years before dying of hemochromatosis at the age of 34. 
Houston concluded that hemochromatosis probably results from excessive 
absorption of iron o~ing either to an inborn error of iron metabolism 
or to multiple transfusions. Heilmeyers (64) also reported a series of 
36 oases of hemochromatosis and stated that the highest incidence is 
between the ages of 50 and 59 and that all oases in females occurred 
after the menopausal age. Althausen Ct) reported 3 oases in females 
among 23 patients with hemochromatosis and found that their menstrual 
history was so abnormal that considerably less blood was lost during the 
reproductive period. 
(2) Studies on iron metabolism - Since the principal alteration in 
this disease is the excessive deposition of an iron-positive p~gment 
(hemosiderin) in most of the organs of the body and the skin, ~ 
~ch a~~en~ion has been paid ~o the me~abolism of iron. Chemical analys~s 
have revealed a high iron content in blood and in all ~he organs varying 
1 (~1_ ..). from 4 to 40 times of normal va ue __ For ins~anoe# normal liver 
con~ains 0.05 ~o 0.1% of iron, but in hemochromatosis the liver contains 
1.15 - 3.65% of iron. Usually, a normal person has a to~al body iron o£ 
3-5 gm, bu~ in hemoohroma~osis the ~otal value may increase up ~o 45 gm. 
Also, in pa~ien~s wi~h hemochroma~osis# the total iron-binding capaci~y 
of serum is normal or low, bu~ the saturation o£ the iron-binding pro~ein 
is high (70). S~udies with radio-active iron (30) have revealed a profound 
depression of u~ilization o£ the iron. Heilmeyer (64), analyzing a series 
o£ 36 oases of hemochromatosis, measured the absorption of iron £rom ~he 
gu~ in these oases by giving radioac~ive iron orally and found increased 
absorp~ion. 
(3) Effao~ of phlebotomy and BAL (Bri~ish Anti-Lewisite; 2,3-dimer-
oap~opropanol; dimercaprol) on hemochromatosis. 
Graniok was probably ~he firs~ (1949) ~o suggest ~hat repea~ad 
venesections might be beneficial to pa~ian~s with hamochrama~osisa 
Recan~ly, there have been evidences tha~ the increased iron con~en~ in 
hemochromatosis can be mobilized for synthesis o£ hemoglobin. Davis and 
Arrowsmith o£ Tulane University, (21, 22) ~reated 3 pa~ian~s wi~h hamo-
ohroma~osis wi~h repeated bleedings and found mobilization of the excessive 
iron manifested by a ~remendous capacity to regenerate red blood cells 
and hemoglobin o£ up ~o 4-7 pin~s of blood par mon~h for a period of 2 
years. This runount of regenerated blood represents a negative iron 
balance of approximately 15-20 gm. per year. The patients also gave 
evidence of subjective improvemen~ clinically$ such as increased energy 
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and working ability, diminution in size of liver, and improvement in 
liver function and in carbohydrate metabolism. Repeated liver biopsies 
also showed a considerable reduction of the concentration of iron in the 
liver and improvement in the cirrhosis. Similar results were reported 
by Houston (71), Warthin (136), Peterson and Ettinger (111) and Beyers 
and Gitlow (6). Whether the bleeding will merely mobilize the iron or 
at the same time modify the hepatic fibrosis, cannot be answered now. 
However, mobilization of iron in hemochromatosis now seems well established. 
Finch and Haskins et al (29~ 62) also noted the failure to develop anemia 
after repeated phlebotomies in patients with hemochromatosis who were on 
normal diets. 
Ohlsson et al (110) reported a case of transfusion hemosiderosis 
after BAL with recovery. The pigmentation of the skin became fainter~ 
the ascites disappeared, and the heart volume and liver funotion became 
normal. This may suggest that BAL also benefits the excretion of iron 
and thus improves the hemochromatosis. 
(4) High frequency of hemochromatosis among South Africans. 
The frequency of hemochromatosis in South Africa has also attracted a 
great deal of attention and has led to many studies. Gillman a·nd Gillman 
(40) found that the diet of South Africans is mainly corn grits, with a 
deficiency of protein and a high iron content. South Africans also 
frequently use iron pots for cooking. It has been found that a typical 
diet cooked in the traditional way in an iron pot may contain 100-150 mg. 
of ir.on per day (133), in contrast to 10-15 mg. for people in other parts 
of the world. Squires (130) reported that abnormally high serum iron 
values are occasionally encountered in adults in South Africa. South 
. 
Africans are also reported to develop hypochromic anemia very rarely. 
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~erritsen and Walker (138) reported the abnormal deposition of iron in 
the tissues of an adult Bantu at autopsy. Gillman and Gillman (41) have 
therefore suggested that this particular type.of chronic malnutrition 
affecting South Africans and the relatively large amounts of iron 
habitually ingested may be etiological factors in hemochromatosis. They 
thought the steady passage of relatively inert iron pigment of large 
molecular size into the circulation cannot be without consequence, pre-
paring the background for development of premature arteriosclerosis, 
cirrhosis of the liver, keloid formation and reticulosis, all of which · 
are known to be prevalent in Africans. Gillman and Gillman (39) by means 
of li~er aspiration biopsy, showed that no less than 12.% of 120 adult 
pellagrins were suffering from frank pigment cirrhosis and that an addi-
tional 18% were in the pre-cirrhotic stage. Consequently malnutrition 
can be regarded as a significant factor in the etiology of pigment 
cirrhosis in Africans. Gore,(44), who also described a white male of 64 
who had pellagra associated with hemochromatosis, thought that the normal 
excretion of excess iron pigment through normal mucosa of the colon is 
defective in pellagra and that the excess depositions of this pigment 
represent a retention, the hemochromatosis in this case being secondary 
to pellagra. 
(5) Copper in hemochromatosis. Copper content in tissues was reported 
to be higher than normal in hemochromatosis (87, 88). Althans.en and Kerr 
(I) stated that in the Black Forest in Germany, where there is increased 
frequency of hemochromatosis, the wine makers spray grape vines with 
copper sulfate for protection against mold and that the inhabitants of 
the area habitually consume more alcohol. These facts led people to think 
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of the possibility of copper poisoning in hemochromatosis; the experimen~ 
tal studies along this line will be reviewed later. 
(B) Experimental Studies 
(l) OVerloading animals vdth iron (Table l). Because the 
absorption of iron is controlled by the intestinal mucosa and normally 
the excretion and absorption of iron are limited, when iron is given 
intravenously the mucosal control is by-passed and iron is almost com-
pletely retained by the body unless there is bleeding (83, 92). Since 
the early 19th century, investigators have given large amounts of blood 
or its components or iron intravenously to animals to ascertain whether 
prolonged administration of iron would produce hemochromatosis. Rous 
and Oliver (121) in 1918 transfused citrated whole blood fram rabbits 
to other rabbits in amounts of 10 cc daily for 6 days out of 7 (about 
195 mg per kilogram of body weight) for 3~6! months and found hemo-
siderosis of organs and tissues such as connective-tissue cells of lungs 
and choroid plexus, spleen, liver cells, Kupffer cells, adrenal glands, 
heart and lymph nodes and central atrophy of hepatic cells. Two of the 
most pigmented liver of 11 animals showed intralobular fibrosis. The 
authors explained the hepatic fibrosis as intercurrent. 
Polson (112) gave large amount of iron (280 mg per kilogram of body 
weight) to rabbits in 1928 for 13 days and observed iron in reticulo-
endothelial cells and pulmonary embolism by iron which was responsible 
for some deaths. He (113) also gave small amounts of iron to rabbits 
for as long as 14 months in 1929 and found 4 of 28 rabbits showing 
slight cirrhosis of liver. Furthermore, (115) he administered iron sub~ 
cutaneously and intraperitoneally to rabbits for l-4 years and in 1933 
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reported that liver cirrhosis and pancreatic damage were absent in all. 
He concluded: ttrt is unlikely .that excess of iron is responsible for 
the hepatic and pancreatic lesions of human hemochromatosis.n Cappell 
(13) in 1930, gave iron in amounts of 550 mg per kilogr~ of body weight 
to rats and mice up to 14 months and found hemosiderosis of organs but 
no cirrhosis. 
In 193.4 Mankin (93), after having injected diluted ferric chloride 
solution intravenously in rabbits for weeks, observed hemosiderosis of 
organs and fibrosis in peripheral portion of the A~lpighian body of the 
spleen. 
Andersson (~), in 1950 reported that large amounts of iron ~67 mg 
per kilogram of body weight) given to rabbits for one year resulted in 
hemosiderosis of organs with no cirrhosis. He stated that his experi-
mental study of the effect of iron administered parenterally to more 
animals and in greater amounts than those employed in any previous 
investigation had not borne out misgivings that parenteral therapy with 
colloidal iron might be well founded. 
Two years later Nissim (104) gave iron in large doses to different 
species of animals for 5-6 months and observed hemosiderosis and d~age 
of hepatic parenchyma, with atrophy of cytoplasm and nuclear pyknosis 
and karyolysis but with no true cirrhosis. 
(2) Copper poisoning and iron feeding. Mallory et al (86) and Hall 
and Butt (59) claimed that large copper feedings or copper injections 
interfered withthe excretion of iron or increased its absorption, 
resulting in deposition of iron in tissues. Necrosis and fibrosis were 
induced at the site of iron deposition in rabbits and sheep. Flinn and 
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Writer Date 
Reported 
Rous & 1918 
Oliver 
(121) 
Polson 1928 
(112) 
.Polson 
(113) 1929 
Cap) ell 1930 (13 
Polson 1933 
(115) 
If. 
TABLE I Experimental Studies on Iron Overloading Reported in the Literature 
Animal Approximately Route of Duration of ,Result 
Used highest amount Administration Experiment 
of elemental 
iron administered 
mg./kg. 
rabbit 195 IV 3-6i months Hemosiderosis of organs 
and central atrophy of 
hepatio cells. 2 of the 
most pigmented livers of 
11 animals showed intra-
lobular cirrhosis. 
rabbits 280 IV 13 days Iron in reticuloendothelial 
oells 1 coecum epithelium$ 
thoracic and abdominal 
lymph glands and tubular 
epithelium of renal 
tubules. Iron also was 
present in vessels as 
emboli • 
rabbit 112 IV 7 days .. 4 out of 28 rabbits showed 
14 months slight cirrhosis of liver. 
rats and 
mice 550 IV 14 months Hemosiderosis of organs. 
No cirrhosis 
rabbits 157 s.c. or I.P. 1·4 years No liver cirrhosis or 
pancreatic damage. 
...... 
(J) 
lfenkin 1934 rabbits *' (93) 
Andersson 1950 rabbits 267 
(3)) 
Nissim 
(104) 1952 Mice 2160 
Rats 
Rabbits 
Guinea pigs 
* Diluted ferric chloride solution (0.25%). 
TABLE I CONTINUED 
I.v. weeks 
I.V. 1 year 
I.v. 5-6 months 
I.P. 
I.e. 
Amount not reported. 
Hemosiderosis in all 
sections of bone marrow 
and half of liver. 
Fibrosis in peripheral 
portion of Malpighian 
follicles of spleen. No 
cirrhosis. 
Hemosiderosis of organs, 
no cirrhosis 
Hemosiderosis of organs. 
Damage of hepatic paren~ 
chy.ma with atrophy of 
cytoplasm and nuclear 
pyknosis and karyolysis. 
No true cirrhosis. Acute 
hepatic necrosis in G.p. 
but without fibrosis. 
1-' 
....:! 
Von Glahn (33) and Polson (114) repeated the experiment and ~ound no 
cirrhosis in experimental animals. Mallory (89) varied the experiment 
by subcutaneous injection o~ copper into rabbits~ sheep~ monkeys and 
guinea pigs in 1931 and explained that the d~~erent result obtained 
by other investigators might be due to di~~erent strains of rabbits. 
Wyatt and Howell (144) observed the e~~ect o~ o.S,% copper acetate mixed 
with a diet containing corn grit and ~ ~erric citrate on rats already 
suf~ering ~rom iron overloading o~ the liver for a period of 72 days. 
Despite the addition o~ copper to the diet~ no di~~erence in the iron 
storage pattern was noted~ and there was no evidence o~ ~ibrosis. 
Chase at al (15) ~ound that there is less absorption of iron from 
gastrointestinal tract o~ rats and swine de~icient in copper than in 
animals supplied with copper. They thought the in~luence o~ copper on 
iron absorption is not due to the administration of copper simultaneously 
with iron~ but appears to be correlated with the level o~ copper in the 
tissues (27). 
Whether the copper poisoning has ~omething to do with hemochromatosis 
is still undecided. 
(3) De~icient diet and iron feeding. Hegsted et al (63~ 77) pro-
duced marked hemosiderosis with corn grit and lard (which are de~icient 
in protein) with excessive iron. They thought that the malnutrition can 
lower the intestinal barrier ~or absorption of iron and also that the 
low phosphorus content of iron-supplemented corn grit diet may be the 
primary cause o~ abnormal high iron absorption. They ~ound that the 
absolute amount o~· iron and phosphorus in the diet as well as the iron-
phosphorus ratio in~luences the amount o~ iron absorbed. The amount of 
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1ron deposited in the liver was inversely related to the phosphorus content 
of the diet. Wyatt and Howell (144) also fed rats with corn grit and 
. I 
' iron salts. They obtained dietary siderosis but no cirrhosis. They con-
firmed the finding that protein deficiency and iron-phosphorus imbalance 
i lead to pathological excess of iron but believe .that some factors other than 
excess of iron are required for the development of liver fibrosis. 
(4) Ligation of the pancreatic duct or extirpation of the pancreas. 
In 1935 Taylor, Stiven and Reid (131) produced siderosis of the liver in 
cats by ligation of the pancreatic duct or extirpation of the pancreas. 
The degree of hemosiderosis was directly proportional to the amount of 
iron in the diet. They thought that cutting off the flow of pancreatic 
juice injured the epithelial cells at the tip of the villi of the small 
bowel and consequently weakened the barrier of iron absorption and 
allowed more iron to be absorbed from food. 
(5) Alloxan poisoning. Herbert, Watson and Perkins (65) reported 
in 1946 that injection of Alloxan caused portal necrosis of the liver in 
10 of 30 rabbits and diabetes and portal cirrhosis in 2 other rabbits; 
one of which developed interlobular and intralobular fibrosis of the 
pancreas. When a reduced form of iron was fed t~ the rabbits freely for 
only ~weeks, a marked deposition of pigment in the spleen, intestinal 
submucosa, liver and renal tubules occurred. This led the authors to 
believe that in hemochromatosis the sequence of events may be as follows: 
(a) Alloxan or an allied substance produces necrosis of the 
peripheral hepatic tissue and islets of Langerhans, resulting in cirrhosis 
of the liver and diabetes. 
(b) Cirrhosis is further aggravated by dietary deficiency. 
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(c) Portal hypertension resulting from cirrhosis of the liver 
produces interlobular~and intralobular fibrosis of the pancreas. 
(d) Abnormal retention of iron derived fram both exogenous and 
endogenous sources results in hemosiderosis. 
Finally6 a review of the clinical and experimental investigations 
indicates no single convincing explanation for pathogenesis of hemo-
ohromatosis; there is still much controversy. 
2. _Exogenous hemochromatosis resulted from prolonged iron 
therapy or repeated blood transfusion. 
(a) In Iron Therapy. 
Iron therapy has long been known to be effective in anemia (119). 
Intravenously administered iron has proved to be almost entirely (71.8-
99.1,%) used for the synthesis of hemoglobin (42 6 137). For this reason6 
intravenous administration of iron appealed to physicians and pharma-
oologists for the emergency treatment of acute anemia and in cases in 
which oral administration is not tolerated 6 but on account of the toxicity 
of intravenous iron salts 6 the application of this therapy did not become 
• 
clinioally established until 19496 when Nissim (99,1001103) standardized 
a safe form of iron for intravenous use--saccharated iron oxide. Though 
immediate toxic reactions or ill effects such as bronchospasm and leuko-
penia resulting from this type of therapy have been reported from time to 
time (69, 81, 1081 138), their incidence and severity have not precluded 
its beneficial use in indicated oases (20 6 341 45, 53, 68, 76, 84, 99, 116 6 
1246 126 1 1276 129). Saccharated iron oxide has been given intravenously 
to anemic patient in as many as 800 injections in 18 months (128) and in 
single doses as large as 1 gm. with no untoward side effect (80, 138). 
~0 
However, 3 patients with chronic anemia not associated with blood loss 
receiving prolonged oral iron therapy developed so-called exogenous hemo-
chromatosis (14, 43, 135). Attention has been called to the possible 
danger o£ insidious tissue damage su~h as fibrosis by excessive storag~ 
o£ iron. It is suggested to give iron intravenously in the minimum 
amount compatible with the patient's comfort and welfare (12, 117). The 
chronic iron poisoning or hemosiderosis resulting £rom intravenous 
administration is not distinctly harmful but is irreversible (16, 19). 
(b) In Blood Transfusion. 
Blood transfusion, which was first given to anemic patients at 
the beginning o£ this century a£ter the discovery o£ the blood group 
in humans, reached its widest use £rom the early 1940 t s to the present, 
hundreds o£ thousand.s o£ bottles o£ blood being given as a general 
panacea £or injuries o£ war with remarkably satisfactory e££ects. The 
first report o£ a transfusion with some claim to be considered beneficial 
to the patient pertained to a case o~ post-partum hemorrhage (8). Today 
blood transfusion is still believed to be the most dramatic, e££ective 
and simple therapy £or acute hemorrhag~s. Administered blood persists 
in the blood stream £e.r longer than any other transfused substance. 
Transfusion thus serves to produce a sustained increase in blood volume 
and also an increase in the oxygen-carrying power o£ blood. As a general 
rule, this method is applied to the treatment o£ anemia only when the 
anemia cannot be cured by the administration o£ iron, liver or other 
hematinics. Transfused blood supplies the recipient with a certain amount 
o£ iron, each 100 ml o£ blood containing some 50 mg •• almost all o£ which 
is present in the £orm o£ hemoglobin. When the red blood cells break down., 
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this iron is retained in the body and can be used by the recipient for 
the for.mation of new hemoglobin. Recently, the reports on transfusional 
siderosis after multiple blood transfusions in anemic patients have been 
increasing in number (5, 7, 9, 35, 73, 85 1 1091 110, 123, 142, 143, 146). 
1ruch attention has been paid to its possible damage to remote tissues. 
The possible association of secondary hemochromatosis with multiple 
blood transfusions was first recognized in 1937 by Kark (75), whose 
patient had received more than 290 transfusions over a period of 9 years 
for aplastic anemia and had developed pigmentation of the skin, impotence 
and a large cirrhotic liver. He assumed that it was due to a failure of 
excretion of excess and nonutilized iron. Since then, many isolated cases 
and collected series of cases have been reported. Opinions differ about 
whether the hemochromatosis results from blood transfusions or from other 
mechanisms. 
Bamford and Rhoads (9) in 1941, reported 3 oases of secondary hemo-
chromat~sis developing after 16 transfusions in 2! years, 12 transfusions 
in 2 years and 54 transfusions in 9 years respectively for refractory 
anemia. All 3 patients showed pigmentation of skin and lymph nodes and 
fibrosis and pigmentation of liver and pancreas. One of them had glyco-
suria. 
In 1942 r~ckey (85) reported a case of aplastic anemia with organ 
changes resembling hemochromatosis after transfusion of 39.8 liters of 
blood in 3~ years. The amount of iron recovered from the patient's 
liver was directly related to the amount of hemoglobin administered in 
transfusions. 
Six years later Schwartz and Blumenthal (123) reviewed 8 oases of 
exogenous hemochromatosis resulting from blood transfusions and reported_ 
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.5 oases of their own. They thought that the hemochromatosis developing 
in these patients was the end result of the deposition and subsequently 
irritating action of the excess amounts of iron in the parenchymatous 
tissues, and that the underlying anemia and the not infrequent trans-
fusion reactions acted as predisposing factors for the development of 
exogenous hemoc~omatosis. 
MUirhead, Crass, Jones and Hill (98) in 1949, observed 5 cases of 
hemosiderosis aggravated by blood transfusions. One patient had 
cirrhosis of liver. The amount of iron in the liver in these oases 
was estimated and found to be approximately equa_l to the total amount 
of' iron in the transfused blood. 
In 1950 Wyatt, !fighton and Moragues (143) described 8 patients with 
severe anemia of diverse causes who were treated by multiple blood trans-
fusions. Post-mortem observations revealed pronounced iron storage. 
Five of these oases showed granular livers; 2 gave chemical assays of 
iron comparable to the levels encountered in conventional hemochromatosis. 
The author.$thought that since these anemic patients are kept alive by 
repeated blood transfusions, it is quite possible that cellular degenera-
tive processes and local nutrient deficits are partially responsible f'or 
tissue siderosis and fibrosis. 
Rath and Finch (118) in 1949, found that in 4 cases of transfusional 
hemosiderosis the serum iron concentration was greatly increased and the 
iron-binding capacity of the serum was fully saturated. 
Four years later Aufderheide et al (5) reported 2 oases of' exogenous 
hemochromatosis with diabetes mellitus after blood transfusions and 
postulated anemia as the basic etiologic factor in secondary hemoohroma-
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tosis by causing increased iron absorption; the iron introduced in the 
form of blood transfusion only accelerates a process already in progress. 
Morningstar reported (94) in 1954~ 3 cases of exogenous hemochroma-
tosis. One patient who received 254 blood transfusions developed pigment 
cirrhosis of the liver~ pigmentation of the skin~ diabetes mellitus and 
testicular atrophy. The wmount of pigmentat~on and fibrosis of the liver 
and pancreas correlated with the number of transfusions. 
Hemochromatosis following homologous serum jaundice nine years 
before death was reported by Aquilina at al (~)~ in 1953. They thought 
that the attack of severe homologous serum jaundice may have initiated 
hemosiderin deposits in various organs of the body. 
3. Relation between idiopathic hemochromatosis and exogenous hemo-
chromatosis. There are two different main opinions regarding the 
relation between the two chief forms of hemochromatosis: 
(A) There are morphological and clinical similarities between 
idiopathic and exogenous hemochromatosis. Brook and Hunter (11) thought 
that hemosiderosis and hemochromatosis are quantitatively rather than 
qualitatively different. Block1 Bethard and Jacobson (7) reported a 
case of acute acquired hemolytic anemia and 3 oases of primary refrac-
tory anemia developing hemosiderosis 1 cirrhosis 1 auricular fibrillation 1 
skin pigmentation~ diabetes mellitus and decreased body hair after 
repeated blood transfusions. They found that at autopsy the tissues 
were practically identical with those of patients with idiopathic hemo-
chromatosis. They thou~ht that the idiopathic and exogenous forms of 
hemochromatosis are similar and possibly identical so far as the type 
and progression of pathological changes of tissues are concerned. The 
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major differences, however, are the extensive chronic anemia present in 
patients with secondary hemochromatosis and the inability to utilize 
iron for erythropoiesis in patients vath hemochromatosis secondary to 
primary refractory anemia. 
(B) The idiopathic and exogenous hemochromatosis are two 
different entities. 
Zeltmacher and Bevans (146) described a patient with aplastic anemia 
associated with hemochromatosis receiving transfus~on of 6.5 gm. Fe, but 
the liver was found to contain 29 gm. of iron. They considered hemo-
chromatosis and hemosiderosis two separate entities and believed that 
transfusion: in aplastic anemia is an unlikely cause of exogenous hemo-
chromatosis. 
Cottier, (18) from Switzerland, and Klechner, Baggenstoss and Weir, 
(78) from the 1~yo Clinic, state that hemochromatosis and transfusion 
hemosiderosis are two distinct and separate pathologic entities, and 
that hemosiderosis was not converted into hemochromatosis because of 
the differences of distribution of iron in organs and the inconstant 
occurrence of cirrhosis of the liver, parenchymatous damage to the 
pancreas, pigmentation of the skin and deposits of iron in bile ducts 
in marked cases of hemosiderosis. They claimed that in idiopathic 
hemochromatosis, the liver is the organ containing the most iron pigment 
deposit, while in exogenous hemochromatosis the spleen is the organ 
with the most iron-pigment deposition. Cottier (18) even thought that 
the co-existence of cirrhosis in transfusional hemosiderosis is due to 
the pre-existing cirrhosis. Gaskell et al (37) observed that in idio-
pathic hemochromatosis the iron pigment is more marked in the ascending 
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~imb of Henle and distal convoluted tubules, while in exogenous hemo-
chromatosis the iron pigment is predominantly in the proximal convoluted 
tubules. 
Thus, there are still many contradictory opinions about the possible 
relation of hemosiderosis to hemochromatosis. Though more people regard 
hemochromatosis as secondary to hemosiderosis, the lack of experimental 
evidence serves as a strong source of debate. 
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MATERIALS AND METHODS 
A total of 103 young male rabbits and 9 young female rabbits weigh-
ing 3.5 to 5.0 Kg (average of 4 Kg) were used. All were kept in individual 
cages and fed with ordinary rabbit pellets, carrots, green vegetables and 
water ad libitum. They were divided into two groups, non-anemic and 
and anemic rabbits. 
A. Non-anemic Rabbits. This group consisted of 58 rabbits; 16 
controls (males) received no treatment, and 42 (7 females and 35 males) 
were repeatedly injected intravenously through the ear veins with 
saccharated iron oxide (Feojeoticn-Smith, Kline and French Laboratories). 
The dosages varied from 20 mg to 200 mg over intervals from 2 days to 2 
months. The total dosages received by each rabbit ranged fram 45 mg to 
4100 mg of elemental iron. Injections were planned every other day to 
start with 20 mg per rabbit, with a 20-mg increase in each succeeding 
injection up to a maximum single dose of 200 mg of elemental iron. The 
longer intervals of injections were occasioned by the development of 
multiple phlebothrombosis of their superficial veins that took time to 
recover so as to become available again for the injection. The rabbits 
were sacrificed over a period of time varying from 4 days to 14 months. 
B. Anemic Rabbits. 54 rabbits were rendered anemic by repeated 
bleedings from the ear veins to maintain a hemoglobin below 6.0 gm per 
100 cc (normal value for rabbit is 13~ 1.2 gm per 100 cc (141) before 
each injection. Seventeen males were used as anemic controls, and 37 
(35 males and 2 females) were injected with iron following the same 
schedule as outlined for the non-anemic rabbits. The period of stuqy 
ranged from 4 days to 12 months, with total corrected dosages of iron 
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~anging from 25 mg to 4040 mg. This dosage was corrected for the iron 
lost through bleeding by subtracting 50 mg iron for each 100 oo of blood 
lost. 
Complete autopsies were performed on rabbits sacrificed at different 
intervals and tissues were fixed in lQ% neutral formalin. Sections of 
the liver, spleen, adrenal, pituitary, thyroid with parathyroid, mesenteric 
lymph nodes, lung, pancreas, skin, kidney, stomach, small bowel, testes 
or ovary, heart and bone marrow (femoral or vertebral) were prepared 
with hemotoxylin-eosin stain and iron stain; aniline blue stain o£ sec-
tions of liver were done in selective oases. 
The urines of rabbits that had received a total of more than 3000 
mg of elemental iron were tested for sugar (Benedict qualitative method) 
together with blood glucose level determinations (modified Folin-Wu 
method). 
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I. Gross examination. 
RESULTS 
.Non-anemic Rabbits 
(1) Control group. Their organs were not remarkable. 
(2) Iron-injected group. The spleens and livers of rabbits receiv-
ing a total of more than 1000 mg. of elemental iron were dark brown and 
enlarged up to twice the normal size and weight. (Average weight of 
spleen was lO.gm. and average weight of liver was 180 gm.). The livers 
of 2 rabbits that were given a total dossage of 3560 mg. (R467-male) 
and 4100 mg. (R257~female) of iron respectively showed brown color with 
irregular nodularity, increased consistency and positive iron stain and 
weighed 200 gm. and 270 gm. respectively (Fig. l-4). The bone marrows 
of most of the animals having received more than 2000 mg. of iron 
totally were also brown in color. 
II. taoroscopio examination. 
(A) Control group: None of the tissues examined in this group 
yielded evidence of the presence of iron-staining material. The liver 
of one rabbit (R 111) demonstrated portal fibrosis with proliferation 
of bile ducts. 
(B) Iron-injected group: The organs in this group of rabbits 
are described in the order of the approximate amount of iron pigment 
found within the tissues. The occurrence of iron pigment in different 
organs is shown in table II. 
(1) §Eleen: The amount of iron present in the spleen appeared 
to bear a direct relationship to the total amounts of iron received by 
each rabbit. Iron-positive pigment granules were present in the phago-
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oytes in the red pulp of every injected animal. In those receiving 
small amounts, the pigment appeared as fine, dustlike granules within 
phagocytes in the pulp. With gradually increasing total dosages, the 
pigment granules clumped together to produce large irregular masses 
found both within the phagocytes of the splenic pulp as well as in 
apparent extra-cellular situations, presumably occasioned by the death 
of the cells bearing such massive accumulations of pigment (Fig. 5). 
The connective tissue cells in the capsule and the trabeculae and the 
endothelial lining cells of the capillary and sinusoids contain 
similar granular golden pigment in those rabbits receiving large 
dosages (over 2000 milligrams of iron). The Malpighian corpuscles were 
well preserved and contained no pigment, and t·he normal architecture of 
the spleen was always retained. No fibrosis was observed. 
(2) Liver: In all of the experimental animals, the liver 
contained large amounts of iron pigment, but apparently in gmounts 
less than that present in the spleen. In rabbits receiving less than 
200 milligrams of iron, the liver showed fine golden-yellow granular 
pigment in the Kupffer cells distributed throughout the hepatic lobules 
(Fig. 6 and Fig 7). With increasing amounts of iron, similar granules 
appeared in the parenchymal cells in the central regions of the lobules. 
With progressive increase in the total iron dose, the pigmentation 
. 
extended toward the periphery of the hepatic lobules, and in those 
receiving the largest doses in the range of 4 grams of iron, large 
masses of pigment granules were present in the peripheral zones. of the 
hepatic lobules (Fig. 8 and Fig. 9). In these last mentioned-animals, 
the total accumulation of pigment appeared to become more marked in the 
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Periportal hepatic cells than in the central hepatic cells. Concomitant• 
with this increase of hepatic parenchymal pigmentation, the Kupffer cells 
showed progressive accumulation of pigment granules as the total dose of 
iron increased (Fig. 10). In animals receiving these large doses, the 
connective tissue cells in the portal spaces and the endothelial cells of 
central veins also contained iron-positive granules. The epithelial 
cells of the bile ducts remained normal at all stages of iron dosage. 
In addition to the hemosiderosis described, 20 rabbits demonstrated 
various degrees of fibrosis in the periportal region (Fig. 11). In 
such animals, iron-positive granules were sometimes present within the 
fibrous tissue. However, the amount of fibrosis was less extensive than 
that observed in the single control animal demonstrating periportal 
fibrosis witheut apparent iron pigmentation. The presence of fibrosis 
of the liver is correlated with the total dosage of iron and duration 
o£ study in Table III and IV. 
(3) Bone marrow: Pigment-laden macrophages were noted in the 
reticular stroma of the bone marrow. The amount of pigment increased 
commensurate with the dose of injected ~ron, but never reached the same 
degree of severity as that present in the liver or spleen. 
(4) Mesenteric LYl!lph Node: Appro:rlmately two-thirds of the rabbits 
showed pigmented macrophages in the sinuses and pigmentation of the 
connective-tissue cells of the capsule and trabeculae. This pigmenta-
tion did not bear any apparent correlation with the dosage of the 
administered iron or the duration of the experimental period. 
(5) ~: Iron-positive granules were present in macrophages 
within the alveoli and in the endothelial lining cells of the capillaries 
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in all rabbits receiving more than 150 milligrams of total iron dosage 
(Fig. 12). No pigment was present in any of the alveolar epithelium~ 
nor in the lining epithelial oells of.the bronchi or bronchioles. No 
iron embolism was found in the vessels of any of the animals. 
(6) Adrenal Gland: Iron pigment was present in almost all of 
the animals in the fibrocytes in the stroma of the adrenal cortex1 ani 
in the connective tissue of the m~dulla. It was also present in the 
cortical cells~ particularly in the zona reticularis and inner half of 
the fasciculata in rabbits receiving doses of iron over 2 grams in 
total amount. Occasional animals demonstrated large, irregular masses 
of iron pigment in these cortical regions, similar to those observed in 
the spleen. This distribution of iron pigment agrees with the finding 
of Nissim {101) who observed a distribution of i~on paralleling that 
of the ascorbic acid in the adrenal; but Nissim stated that the adrenal 
medulla was invariably free of iron in all of his experimental animals 
(105). 
. (7) E,ituitary gland: Small amounts of fine granular iron 
pigment were present in the fibrous stromal cells of rabbits having 
received more than 300 milligrams of iron. No pigment was ever noted 
in the glandular cells of the anterior pituitary. 
(8) K;idney: Fine granular iron pigment was present in the 
endothelial cells of the glomerular capillaries and in the tubular 
epithelial cells of the ascending limb of Henle's loops and collecting 
tubules. This distribution was most evident in animals rece~ving the 
larger doses of iron. The proximal convoluted tubules were never 
involved, and no iron-staining material was noted in the tubular lumens. 
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(9) Parathyroid gland: As in the pituitary~ ~ine granular 
iron-positive pigment was present in the connective tissue stromal cells~ 
but none in the epithelial cells o~ the glands. 
(10) ~ary: Iron-positive pigment was present in the stromal 
cells and central scars o~ corpora lutea in rabbits that had received 
more than 2500 milligrams o~ iron. No such pigment was ~ound in the 
~ollicles or ger.minal epithelium. This pattern o~ pigment distribution 
again agrees with the ~indings o~ Nissim (102)~ who observed the correla-
tion between the distribution o~ iron and that o~ ascorbic acid in the 
ovary as well as in the adrenal. Nissim thought that a metabolic 
association between iron and ascorbic acid was possible. 
(11) 'J,'estas:. Scanty amounts o~ ~ine iron pigment granules 
were occasionally present in the interstitial tissue of testis in rabbits 
given more than 500 milligrams of iron and in all those having received 
more than 3500 milligrams o~ iron. 
(12) Skin: Iron pigment was present in the hair follicles and 
=--
some connective tissue cells in the corium o~ rabbits that had received 
more than 700 milligrams o~ iron. This finding was not constant, however~ 
and iron pigment did not appear in all animals, even in those having 
received maximum total dosages. No iron pigment was present in the 
epidermal cells. The sweat glands were absent in all the sections o~ 
skin examined, so the distribution of iron pigment in sweat glands cannot 
be evaluated. 
(13) ~ancreas: Scanty amounts o~ ~ine iron granules were noted 
in some o~ the acinar cells and some o~ the islet cells in rabbits having received 
more than 400 milligrams of iron. This pigmentation, however~ was not 
eonsta.nt and was not present in all animals,. even in those with maximum 
dosage. Fibrosis was not noted in any of the rabbits, and no total de-
struction of islet cells was ever present. 
(14) Thyroid: In a few rabbits having received more than 1400 
milligrams of iron,. occasional fine iron pigment granules were noted in 
the stromal cells. No pigment was present in the follicular cells in 
any animal. 
(15) Heart;: Iron pigment was present in the endothelial cells 
of the endocardium in scanty amount in all rabbits~ and in the muscle 
fibers of the myocardium in only a very few animals, without apparent 
correlation with the total dosage of iron administered. 
(16) Gastrointestinal tract: Iron pigment was present in the 
capillary endothelium of most of the rabbits. It appeared in the stromal 
cells of the mucosa in the stomach of one animal (R 726) and in the 
mucosal fibro-blasts in the small bowel of an additional animal (R 135). 
No iron pigment was ever noted in the mucosal epithelial cells of any 
animal. 
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TABLE II 
. 
OCCURENCE OF IRON PIGMENT IN VARIOUS ORGANS OF NON-ANEMIC EXPERIMENTAL 
RABBITS* 
Rabbit Iron Liver Spleen Adre- Pitui- Parathy- Lymph Lung Pan- Skin 
No. injected nal tary roid node ere as 
(mg.) 
R342 45 f/ f ~ 0 •••• 0 0 0 0 Rl38 80 ~ ~ 0 •••• 0 0 0 0 R569 80 0 •••• 0 0 0 0 
Rll4 105' ~ ~ ~ 0 .... .;. 0 0 0 RlOO 15'0 0 .;. 0 .;. 0 0 
R44 150 ~ ~ f. 0 0 0 ~ 0 0 R384 200 .;. 0 .;. 0 0 0 
Rl73 215' ~ ~ ~ 0 0 0 .;. 0 0 R 28 31.0 .;. ~ ~ .~ 0 0 R539 365 ~ ~- ~ ~ 0 0 R 54 385 ~ .;. ~ 0 0 R35'3 390 .;. ~ ~ 0 0 0 Rl28 395 ~ ~ 0 .;. 0 0 R 84 440 ~ •••• ~ .;. 0 0 R$25' 5'20 ~ f .;. 0 0 R247 800 ~ ~ •••• 0 ~ 0 0 Rl35' 980 ~ .... .;. 0 0 Rl$0 1000 .;. 0 ~ ~ 0 l R562 1.080 ~ ~ ~ ~ •••• .;. 0 R873 llOO •••• ~ 0 0 R869 111.0 ~ ~ ~ .;. ~ ~ 0 1-R717 1150 ~ 0 0 0 R732 1.150 1- .;. .;. 1- ~ 1- 0 0 Rl65 1200 .;. ~ ~ ~ •••• f 0 0 R476 1200 ~ ~ ~ ~ 0 0 R65'1 1265' ~ 0 0 R600 1300 ~ ~ ~ ~ 0 0 R722 1400 ~ ~ 0 .j 0 R 2 1430 ~ f f ~ 0 0 R372 l46o f .;. ~ .;. .;. 0 R324 1650 ~ ~ ~ ~ ~ 0 0 R552 1700 ~ 0 t R430 1810 .;. f ~ ~ 0 0 0 0 R726 1900 ~ ~ ..... f ~ 0 0 R$76 2115 ~ ~ ~ 0 ~ 0 R369 2125 .;. .;. f .;. f Rl32 ~945 ~ 1- .;. 1- -I- f 1- 0 R723 3000 f ~ 1- 0 1- 1- 0 0 R357 3060 ~ ~ ~ 1- f ~ ~ 1-Rh67 35'60 ~ ~ ·~ ~ R720 3960 1- ~ ~ ~ ~ R257 4100 1- .f 1- 1- 0 
* 1- - present; 0 -absent; •••• -tissue was not examined. 
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TABLE II (Continued) 
Rabbit Iron Kidney. Stomach B~1 Thyr..oid Test'-s Ov~ry Mypcar- Bone 
No. injected di\.un ~row 
(mg) 
* 
R342 45 0 0 0 0 0 •••• 0 
R138 80 0 0 0 0 0 ..... 0 
R569 80 0 0 0 0 0 ...... 0 ~ R114 105 0 0 0 0 0 •••• 0 
R100 150 0 0 0 0 0 •••• 0 ~ R 44 150 0 0 0 0 0 •••• 0 
R384 200 f. 0 0 0 0 •••• 0 ~ R173 215 ~ 0 0 0 0 •••• 0 R 28 310 0 0 0 0 •••• 0 ~ R539 365 ~ 0 0 0 0 •••• 0 R 54 385 0 0 0 0 •••• 0 ~ R353 390 0 0 0 0 0 •••• 0 
R128 395 J 0 0 0 0 •••• 0 ~ R 84 440 0 0 0 0 •••• 0 
R525 520 0 0 0 0 
"- •••• 
0 ~ R247 800 J 0 0 0 I •••• 0 R135 980 0 I 0 0 •••• 0 ~ R150 1000 0 0 0 0 0 •••• 0 
R562 1080 0 0 0 0 I •••• 0 ~ R873 1100 ~ 0 0 0 •••• 0 0 R869 1100 0 0 0 ~ •••• 0 ~ R717 1160 I 0 0 0 •••• 0 
R732 1150 0 0 0 0 0 •••• 0 ~ R165 1200 0 0 0 0 0 •••• 0 
R476 1200 ~ 0 0 0 0 •••• 0 ~ R651 1265 0 0 0 0 ..... 0 
R600 1300 ~· 0 0 0 0 ..... 0 ~ R722 1400 0 0 I 0 •••• 0 
R 2 1430 ~ 0 0 0 0 •••• 0 ~ R372 1460 0 0 0 •••• 0 0 
R324 1650 ~ 0 0 0 I •••• 0 ~ R562 1700 0 0 0 0 •••• 0 
R430 1810 ~ 0 0 0 0 •••• 0 ~ R726 1900 ~- 0 I 0 ..... I 
R576 2115 ~ 0 ;:JO 0 0 •••• 0 ~ R369 2125 0 0 0 •••• 0 0 
R132 2945 ~ 0 0 0 0 •••• 0 ~ R723 3000 0 0 0 ..... ~ 0 R357 3060 ~ 0 0 0 •••• 0 ~ R467 3560 0 0 0 I •••• I 
R720 3960 ~ 0 0 ~ •••• ~ 0 ~ R257 4100 0 0 •••• 0 
RABBIT 
{\. 
TABLE III 
EXPERDrn:NTS ON NON-ANEMIC RABBITS 
TOTAL DOSE OF ELEMEN'!PAL 
moN 
T D.rn: FROM: FmST 
INJECTION TO DEATH 
FIBROSIS OF 
LIVER * 
~~~---------------------------------------------------------------------
mg. month 
M~ ~ ~ 0 
R138 80 1/~ 0 
R569 80 1/3 0 
nu ~ ~ o 
R100 150 1/2 · - 0 
R 44 150 1/2 0 
MM ~ 0 0 
n~ ~ 0 o 
R 28 310 l 0 
R539 365 2 0 
R 54 385 2 ,t 
R353 390 2 0 
R128 395 1 0. 
R 84 440 3 ,t 
R525 520 1 0 
R247 800 1 0 
R135 980 1 0 
R150 1000 2/3 0 
R562 1080 1 ,t 
R873 1100 2 0 
R869 1110 2 2/3 " 
R717 1150 3 r. 
R732 1150 1 1/3 . ~ 
R165 1200 1 r. 
R476 1200 3 ~ 
R651 1265 1 r. 
. R600 1300 5 I 
R722 1400 3 0 
R 2 1430 3 1/3 6 
MH ~0 7 r 
R324 1650 2 2/3 0 
R552 1700 3 6 
R430 1810 8 r. 
R726 1900 7 f 
R576 2115 4 0 
R369 2125 11 1/2 ! 
R132 2945 ~1 1/2 I 
R723 3000 __ 7. . •. 0 
R357 3060 12 ~ 
R467 3560 13 r 
R720 3960 8 1/2 0 ~e~Z------------~!~~-----------------~-!~----------------------t-----------
* a ---- absence of fibrosis 
~ ---- presence of fibrosis 
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TABLE IV 
Incidence of Hepatic Fibrosis Among the Total Experimental Non-anemia 
~ Rabbits. 
!TOTAL DOSAGE NUMBER OF RABBITS NUMBER OF RABBITS 
RANGE , INJECTED o moN SHOWING HEPATIC 
FIBROSIS 
MG. 
45 - 100 13 1 
' 
401 - 1000 5 1 
1001 - 2000 16 13 
2001 - 3000 4 2 
3001 - 4100 4 3 
'$> RABBITS WITH 
HEPATIC FIBROSIS 
AlJ!Ol'JG THE TOTAL 
EXPERIMENTAL .... 
RABBITS 
% 
8 
20 
81 
50 
75 
38 
At\emic Rabbits 
I. Gross examination: 
(l) Control group: Their organs were not remarkable except that the 
liver of one rabbit (R 40) showed slight nodularity and increased consis-
tency1 but no change in color. 
(2) Iron-injected group: The organs were similar to those of 
the non-anemic rabbits except that none o£ livers showed gross nodularity. 
II. Microscopic examination: 
(1) Control groups: None o£ the tissues o£ this group o£ rabbits 
shcw;ed the presence o£ iron-staining material. Two rabbits (R 40 and 
R 103) showed marked portal fibrosis with proliferation o£ the bile ducts 
and disruption of the normal architecture of the liver. These hepatic 
changes appeared to be completely unrelated to the presence o£ any iron 
pigmentation. 
(2) Iron-injected group: In general the distribution o£ iron pigment 
in this group of anemic rabbits paralleled that of the non-anemic rabbits. 
The tissue sections in general resembled almost precisely those described 
in the iron-injected group of non-anemic rabbits. The occurrence of iron 
pigment in different organs is shown in table v. Whereas 20 out o£ 42 
non-anemic iron-injected rabbits showed some fibrosis of the liver 1 in 
this anemic group 8 rabbits out of 37 showed similar fibrosis 1 periportal 
in distribution 1 associated with the hemosiderosis. The correlation 
between fibrosis o£ the liver and the wnount of iron injected and duration 
of experimentation are presented in tables VI and VII. 
Glycosuria was never demonstrated in any of the experimental 
animals and the blood sugar levels of all rabbits 1 both anemic and non-
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anemic~ failed to disclose any hyperglycemia. All determinations fell 
within the nor.mal range of 100-120 mg. of glucose per tOO o.c. of blood. 
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TABLE V 
OCCURREHCE OF mON PIG!IlENT IN VARIOUS ORGANS OF ANEl\UC EKPERIMENTAL RABBITS* 
! 
Rabbit Iron Liver Spl~en Adrenal Pitu~- Parathy- Lymph Lung Pan- Skin 
No. injected tary: roid node oreas 
(mg.) 
l lil79 '25 ~ f 0 •••• .0 0 0 0 R226 70 I ~ 0 ••••• 0 0 0 0 R283 75 ~ 0 •••• 6 0 0 0 Rl22 75 j j 0 •••• f 0 0 0 R293 80 ~ 0 •••• 0 0 0 0 R287 80 ~ ~ 0 0 0 0 0 0 R277 95 ~ 0 •••• 0 0 0 0 R 27 150 ~ ~ 0 0 0 j 0 0 R436 175 ~ I ! 0 0 0 0 R202 185 ~ ''1. 0 0 ~ ~ 0 0 " i R189 205 ~ .I 0 f 0 0 R234 210 ~ ~ ~ i ·-· .. ~ ~ 0 0 R284 315 ~ 0 0 0 R300 330 ~ ~ ~ 0 0 ~ 0 0 R473 330 ~ f .I 0 0 R292 385 ;. ~ ~ •••• 0 ~ 0 0 R~65 425 ~ •••• 0 0 0 R286 435 ~ ~ ~ •••• 0 ~ 0 0 R 89 470 ~ ~ ~ f 0 R488 530 ~ -~ ~ ~ 0 0 R444 700 ~ ~ I 0 I R464 730 ~ ~ ~ 0 ~ 0 0 R315 790 ~ •••• f 0 I R245 830 ~ ~ ~ ~ 0 ~ 0 0 . - R288 1220 I ~ 0 0 
' 
R232 1320 ~ ~ j j I I 0 I - .> R304 1360 ~ 0 0 0 /, •••• R294 1575 ~ ~ ~ ~ •••• ~ 0 0 R587 1850 •••• 0 0 0 
R714 2700 ~ j ~ ~ 0 ~ ~ 0 0 R224 2800 •••• 0 I 
R374 2930 
·l ~ ~ ~ ..... I I 0 g R278 3100 ~ ~ ~ 0 0 0 R727 3160 ~ ~ ~ ~ I ~ R323 3400 j •••• ~ 0 R715 4000 ~ ~ ~ ! I ~ ~ I R44l 4040 I •••• ·~·· 0 
* I present; 0 - absent; •••• - tissue not examined 
• ! 
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TABLE:V (Continued) 
-
Rabbit Iron , Kidney Stomach Bowel Thyroid Testis Ovary MYocar- Bone 
No. injected ( .) dium marrow 
R179 25 0 0 0 0 0 •••• 0 0 
R226 70 0 0 0 0 0 •••• 0 I 
R283 75 0 0 0 0 0 •••• 0 0 
R122 75 0 0 0 0 0 ... -. 0 ~ R293 80 0 0 0 0 0 •••• 0 
R287 80 0 G 0 0 0 •••• 0 ; R277 95 I 0 0 0 0 •••• 0 
R 27 150 0 0 0 0 0 •••• 0 j R436 175 0 0 0 0 0 •••• 0 
R202 185 0 0 0 o. 0 •••• 0 ~ R189 205 ~ 0 0 0 0 •••• 0 R234 210 0 0 0 0 •••• 0 ~ R284 315 0 0 0 0 0 .... 0 
R300 330 0 0 0 0 0 •••• 0 ~ R473 330 ~ 0 0 0 0 •••• 0 R292 385 0 0 ·0 0 •••• 0 ~ R465 425 ~ 0 0 0 0 •••• 0 R286 435 0 0 0 0 •••• 0 -;_ 
R 89 470 ~ 0 0 0 0 •••• 0 ·l R488 530 0 0 0 I •••• 0 ~ R444 700 0 0 0 0 ·0 •••• 0 
R464 730 0 0 0 0 ~ •••• 0 ~ R315 790 ~ 0 0 0 •••• 0 R245 830 0 0 0 0 •••• 0 ~ R288 1220 ~ 0 0 0 0 •••• 0 ' R232 1320 0 0 0 ~ •••• 0 ~ __ , "' R304 1360 0 0 0 0 0 •••• 
R294 1575 0 0 0 0 I •••• 0 ~ R587 1850 ~ 0 0 0 0 •••• 0 R714 2700 0 o. 0 •••• I 0 ~ R224 2800 ~ 0 0 0 I •••• 0 R374 2930 0 0 0 0 •••• 0 j R278 3100 j 0 0 I 0 •••• 0 R727 3160 0 0 0 •••• I 0 ~ R323 3400 ~ 0 0 0 ~ •••• I R715 4000 0 0 ~ •••• 0 ~ R441 4040 I 0 0 I •••• I 
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~ABLE VI 
~ERI1mNTS ON ~ITC RABBITS 
~------------------------------------------------------------------------
:aABBIT ~OTAL DOSE J;RON toss .CORRECTED .TIME FROM FIBROSIS 
OF IRON BY BLEEDING TOTAL DOSE FIRST INJEC- OF 
INJECTED OF IRON TION TO DEATH LIVER* 
--------------------------------------------------------------------------
.... mg. mg • mg. month 
R179 100 75 25 1/7 0 
R226 120 50 70 1/3 0 
R283 125 50 75 i/2 0 
R122 225 150 75 2/3 0 
R293 140 60 80 1/3 0 
R287 260 180 80 1/5 0 
R277 165 70 95 1/2 0 
R 27 200 50 150 1/4 0 
R436 215 40 175 1/2 0 
R202 245 60 185 1/5 0 
R189 330 125 205 1/2 0 
R234 300 90 210 1 0 
R284 465 150 315 1 1/2 0 
R300 505 175 330 1 1/2 0 
R473 400 70 330 1 0 
R292 495 110 385 1 0 
R465 490 65 425 1 1/2 0 
R286 510 75 435 1 0 
R89 539 69 470 1 1/2 ;. 
R488 650 120 530 2 0 
R444 825 125 700 2 1/~ ~-
;; R464 855 125 730 1 1/2 0 
--' R315 985 195 790 2 0 
R245 1005 175 830 2 1/2 0 
R288 1720 500 1220 4 0 
R232 1600 280 1320 6 0 
R304 1582 222 1360 7 ~ R294 1860 285 1575 7 1/2 
R587 2050 200 1850 8 I 
R714 3100 400 2700 7 1/2 0 
R224 3300 500 2800 9 ;. 
R374 3530 600 2930 11 1/2 0 
R278 3416 316 3100 12 ~ R727 3590 430 3160 7 
R323 4100 700 3400 12 0 
R715 4750 750 4000 8 0 
R441 4790 750 4040 12 0 
--------------------------------------------------------------------------~ 
* 
0 ---- absence ar fibrosis f ---- presence of fibrosis 
TABLE VII 
Incidence of Hepatic Fibrosis Among the Total Ane.mio Experimental 
· Rabbits 
~~------------------------------------------------------------------------TOT.AL DOSAGE 
RANGE OF IRON 
NUMBER OF RABBITS 
INJECTED 
NUMBER OF RABBITS 
SHOWING HEPATIC 
FIBROSIS 
RABBITS WITH 
HEPATIC FIBROSIS 
.AMONG TEE TOTAL 
EXPERIMENTAL 
RABBITS 
--------------------------------------------------------------------------MG. % 
25 - 400 16 0 0 
401 - 1000 8 2 25 
1001 - 2000 5 3 60 
2001 - 3000 3 1 34 
3001 - 4040 5 2 40 
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DISCUSSION 
These experimental observations permit certain conclusions with 
respect to the questions presented in the introductory section: 
l) What is the pattern of progressive experimental iron overload in 
rabbits? In both the anemic and non-anemic rabbits, a fairly clearly-
defined sequence of tissue changes is apparent. This pattern appeared 
to be directly related to the total amount of iron administered to each 
animal, and did not appear to be modified by the presence or absence of 
anemia. In animals receiving the smaller total dosages of iron, iron 
pigment identical with hemosiderin was first noted in the reticulo-
endothelial cells of the body and in phagocytic macrophages. The most 
intense pigmentation affected the phagocytic endothelial cells of the 
splenic sinuses and Kupffer cells of the liver. Pigment was also present 
in reticulo-endothelial cells of the bone marrow and lymph nodes. With 
progressive increase in iron overload, masses of iron pigment were found 
in the splenic pulp, in apparently extracellular locations, suggesting 
that death of the phagocytic cells had occurred with deposition of the 
pigment accumulations into the intercellular spaces. In the liver, with 
progressive iron overload, after the Kupffer cells had become completely 
stuffed, iron pigment progressively accumulated in the hepatic cells. 
This pigment appeared first in the central zones of the hepatic lobules, 
but with the largest doses, the entire lobules soon became affected. In 
animals receiving approximately 4 grams of iron, large masses of pigment 
were found in the periportal regions. At these maximum dosage levels, 
the amount of iron pigment appeared to become more extensive in the 
peripheral regions of the hepatic lobules than in the central zones. 
In certain animals~ this intense hepatic pigmentation was associated 
with some increased periportal ~ibrous tissue~ suggesting the development 
o~ a pigment cirrhosis. This will be discussed more fUlly a little later. 
No pigmentation was present in the bild duct epithelium. These 
findings agree with those of previous investigators (13 1 32~ 104~ 107, 112, 
122, 132). 
The pancreas in most animals was only minimally af~ected by the iron 
overload. In a few instances, iron pigment was noted in the acinar cells 
and islets o~ Langerhans. This ~inding, however~ was quite inconstant 
and was never associated with any pancreatic ~ibrosis. No signi~icant 
structural change was noted in these rabbits, and the intensity o~ 
pigmentation was of far less significance than that ~ound in most clinical 
cases of well-advanced hemochromatosis. It is noteworthy that no 
abnormal~ties in carbohydrate metabolism ware ever detected in any o~ the 
animals, however large the total dose o~ administered iron. Pigmentation 
was also noted in the stromal connective tissue cells o~ many of the 
glandular organs, such as the testes, thyroid~ parathyroid and pituitary 
glands. In none o~ these situations was there signi~icant pigmentation 
o~ the parenchymal cells. Iron pigment was noted in the hair ~ollicles 
and in some connective tissue cells in the corium of rabbits receiving 
more than 700 milligrams of iron. This ~inding, however, was inconstant 
and did not appear to be related to either the total dosage of iron or 
the duration o~ the deposit. 
These anatomic changes do not completely parallel those observed in 
the usual classical cases o~ clinical hemochromatosis. However, the 
progressive pattern of deposition a~~ecting the reticulo-endothelial cells, 
iiver, glandular organs, and skin strongly suggests a resemblance to 
clinical hemochromatosis, particularly cases that have been described 
as exogenous hemochromatosis. It is possible that if the experiment 
had been carried further, both with respect to the total amount of iron 
administered and the duration of the study, the tissue cllanges may have 
progressed to a more close resemblance to clinical hemochromatosis. 
2) Will prolonged and intensive administration of iron progress 
from simple iron pigmentation of tissues to structural changes, such as 
pigment cirrhosis? The experimental observations suggest that there is 
a relationship be~veen intense hemosiderosis of the liver and the 
development of pigment cirrhosis. Periportal fibrosis was noted in 20 
(4'7%) o£ the non-anemic rabbits and in 8 (22%) of the anemic rabbits. 
However, it must be noted that one control animal in the non~anemic 
group and two in the anemic control group showed a portal ~pe 
cirrhosis unassociated with iron pigment - an incidence o£ 10% of the 
control animals in both groups. These cases of cirrhosis in the control 
animals are interpreted as incidental hepatic changes in the general 
population of this experimental animal. These incidental findings, how-
ever, do not invalidate the significantly higher incidence of cirrhosis 
:round in the experimental animals. The results therefore strongly 
suggest that intense iron pigmentation may be causally related to the 
development of hepatic fibrosis and the development of an anatomic 
pattern resembling pigment cirrhosis in humans. These findings support 
the statement made by Brook and Hunter (ll) that the difference between 
hemosiderosis and hemochromatosis is a quantitative rather than a quali-
tative one. The mechanisms by which the progressive hemosiderosis 
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produces such hepatic fibrosis are still not clear. lfullory (86) 
'suggested that the hemosiderosis itself induces necrosis of liver cells 
and fibrosis of the hepatic parenchyma. Schwartz (123) supported this 
view by postulating that the macroparticles may cause damage to cells 
and create fibrous scarring. (;-ranick ·{51) proposed that the fibrosis 
may be due to the improper storage of iron in individuals already suffer-
ing from some underlying hepatic infection. Himsworth (67) also con~ 
sidered the pigment to be causally related to the development of hepatic 
fibrosis. However$ he favored the view that the overloading of the 
Kupffer cells may# by producing circulatory disturbances# result in 
hepatic damage and fibrosis. It is noteworthy that no direct evidence 
of hepatic cell necrosis was identified in the experimental animals, 
even in those that received maximum dosages and developed hepatic 
fibrosis. With respect to the liver, the conclusion cannot be escaped 
that the iron pigmentation we.s in some way causally related to the 
occurrence of a higher than anticipated incidence of hepatic fibrosis, 
suggesting a pigment cirrhosis. Significant structural changes were not 
associated with the iron pigmentation in other organs. This observation 
was not unanticipated, since in many clinical cases of hemochromatosis 
the pigmentation does not appear to give rise to or be associated with 
structural change. 
3) Is the amount of iron deposit or the duration of the deposit 
the more important factor in the development of cirrhosis? The 
experimental results obtained do not permit any conclusive observation 
with respect to this question. It can be seen from Tables III and VI 
that the fibrosis occurred in a sporadic, haphazard pattern. Certain 
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~nimals receiving rather small amounts of iron developed hepatic fibrosis, 
whereas other animals receiving similar amounts over an identical period 
' of time failed to disclose tissue changes. There was no clear correla-
tion between the total dose of iron and the appearance of cirrhosis of 
the liver. In many animals receiving the maximum dosages, hepatic 
changes failed to develop, whereas cirrhosis vms noted in animals with 
considerably smaller emounts of administered iron. In the anemic group 
o£ rabbits, the three animals receiving the largest amounts of iron 
failed to develop hepatic change. Neither was there any correlation 
with time, since in many rabbits cirrhosis appeared within 2 to 3 months~ 
whereas longer term animals showed no apparent structural fibrosis. The 
experimental results therefore do not permit any conclusion as to the 
specific factors which may have been important in this random pattern 
of development of hepatic fibrosis. 
The incidence of cirrhosis observed in the present experiment is 
somewhat higher than that reported by previous authors (see Table I). 
This observation suggests the possibility that earlier experiments may 
have £ailed to develop hepatic fibrous changes either because insufficient 
total dosages of iron were administered, or the rate of administration 
may have been too slow. It is of interest to compare the largest total 
dose of iron injected in this experiment, 4.1 gm, with the largest 
amount of iron reported in patient with hemochromatosis, 54 gm. The 
·4.1 gm of iron for a rabbit weighing 4 kg is comparable to the 72 gm in 
an average humanweighing 70 kg. This experimental dose of 4.1 gm of 
iron is further equivalent to 288 transfusions (500 mg. of iron in 1000 
c.c. of blood) given to a patient. 
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4) Is anemia an additional factor in the development of tissue 
damage in iron overloading? As can be seen from the experimental results 
presented~ the presence of anemia did not appear to materially affect the 
development of structural changes in organs. 
to favor the development of hepatic fibrosis. 
The anemia did not appear 
Howell and Wyatt# (73) 
in discussing the development of pigmentary cirrhosis in Cooley's 
anemia, pointed out that the recurrent~ nonresponsive bouts of anemia 
may, through oxygen deprivation, affect hepatic or other cells with a 
high metabolic level~ inhibiting their enzyme system and resulting in 
degenerative cellular changes and consequent fibrosis. Schwartz and 
Blumenthal (123) also emphasized the contributing role of the anoxia 
due to anemia. Wyatt, Mighton and Moragues (143) considered a local 
nutritional deficit in anemia to be another factor in the development 
of parenchymal fibrosis. Thus, anemia exerts its effect mainly through 
tissue anoxia and the local nutritional deficit. This hypothetic 
possibility that tissue anoxia might potentiate the damaging effect of 
iron pigment was not borne out by this experimental observation. Also 
it is not unlikely that in the present experiment, the anemia caused 
by bleeding was always corrected within a short time by the iron injec-
tions. This gave no opportunity for the anemia to last for any 
significant period so as to produce sufficient tissue anoxia and local 
nutritional deficit and thus to favor the development of hepatic fibrosis. 
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SU1~Y AND CONCLUSION 
Repeated intravenous injections of saccharated iron oxide were 
administered to 42 non-anemic rabbits and 37 rabbits rendered anemic by 
bleeding# up to a maximum dosage of 1025 milligrams per kg of body weight. 
I 
The longest duration of experimental observation was 14 months. A pro• 
gressive pattern of iron pigment deposit in the body was apparent, affect-
ing first the reticulo-endothelial system and then particularly the 
hepatic parenchymal cells. Twenty of the 42 non-anemic rabbits and 
8 of the 37 anemic rabbits developed varying degrees of portal fibrosis. 
This portal fibrosis was in all cases associated with intense deposits 
of iron pigment in the peripheral zones of the hepatic lobule. There 
was no clear evidence rela~ing the occurrence of fibrosis to either 
the total amount of iron administered or the duration of the iron 
deposit. Certain anatomic resemblances between exogenous and endogenous 
hemochromatosis in humans were noted suggesting the possible relationship 
of progressive hemosiderosis in rabbits to the development of tissue 
changes resembling the clinical hemochromatosis. 
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APPENDIX 
Figure 1 . Liv!ffi OF RABBIT #467 , SHaNING 
IRREGULA1"1 NODULAR SURFACE . 
Figure 2 . LIVER CF RABBIT 7;257 , SEOVUNG 
:rn.REGULAR NODULAR SURFACE . 
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Figure 3 . ABOVE: LEFT LOBE OF THE LIVER OF RABBIT #257 . 
BELOW: COR:tESPOHDING LOBE OF THE LIVER <F A 
CONTROL RABBIT FOR CO!PARISON OF SIZE, 
COLOR .Al"'ID SURFACE AFPEA.RAECE . 
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figure 4. PARENCHYMAL SURFACES CF LIVERS STAINED BY 
POTASSIUM FERROCYANIDE - HYDROCHLORIC ACID: 
ABOVE: FROM RABBIT #257 SHOWING STRONGLY POSITIVE 
IRON REACTIOO 
BELOW: FROH A Ca.TTROL P.ABBIT SHOWING NIDATIVE 
IROI~ REACTION. 
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Figure 5. SECTION OF SPLEEN OF RABBri' =1/=132. NOTE LARGE 
AND SHALL mREGULAR MASSES CF PIGMENT GRANULES 
IN THE SPLENIC PULP AND THE WELL-PRESERVED 
NALPIGHIAN CORPUSCLE CONTAIND!G NO PIGMENT. 
HIDTATOXYLIN AND EOSIN. LOW POWER. 
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Figure 6 . SECTION OF LIVER OF RABBJT ~84. NOTE THE 
maN- POSITIVE GRANULES IN KUPFFER CELLS 
THROUGHOur THE HEPATIC LOBULES. moN STADT 
LOV'f PGV'ER . 
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Fip;ure 7. HIGH'SR HA.GNIFICATION OF TBE SAME SECTION OF 
THE LIVER OF RABBIT ~/.:384 AS SHO\iiJN IN FIG . 6 . 
mON STAIN • HIGH POWER . 
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Figure B. SECTICN OF LIVER OF RABBIT :f/=324 . NOTE IRON-
POSITIVE GRANULES IN ALL HEPATIC CELLS WITH 
GREATER AMOUNTS IN THE PERIPORTAL HEPATIC 
CELLS AS vVELL AS lll KUPFFER CELLS . IRON 
STAIN . LOVv POWER . 
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Figure 9 . SECTION OF LIVER CF RABBIT #257 . NOTE 
IRON- POSITIVE GRAHULES IN ALL THE HEPATIC 
CELLS AS WELL AS IN THE KUPFFER CELLS AND 
LARGE MASSES OF PIGMEHT IN THE PERIPHERAL 
ZONES OF THE HEPATIC LOBULES. THERE IS 
ALSO SLIGHT DEGREE CF FIBROSIS IN THE 
PERIPORTAL AREAS . IRON STAIN . LOW POW"ER . 
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Figure 10 . SECTION OF LIVER OF RABBIT :/;:720 . NOTE 
THE ::ARKED DIDREE OF :HEPATIC PAREECHTI::AL 
PIG1.lENTATION AND ACCUHULATI01; OF LARGE 
HA.SSES CF PIGI:iENT Til KUPF'FER CELLS . IRON 
STAIN . LOO POWER . 
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Figure 11 . SECTION OF LIVER OF RABBIT :ff'726 . NOTE 
VARIOUS DIDREES CF FIBROSIS m THE PERI-
PORTAL RID IONS. .ANTI.INE BLUE STAIN . LOW 
POW'i'....R . 
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Figure 12 . SECTION OF LUNG OF RABBJT #357 • :UOTE THE mON-
POSITIVE GRANULES IN HACROPEAGES AND IN THE 
ENDOTHELIAL LINING CELLS OF THE CAPILLARJES 
BUT NO PIGMENT IN ANY OF THE .ALVEOLAR 
EPITHELIUM. ffiON STAIN. LO'Il POWER . 
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I· 
f'or 
The increasing incidence of transfu~ional hemochromatosis after 
i 
peated blood transfusions in anemic patients and the similarity of 
morphological changes between the transfusional and idiopathic 
I 
have suggested that the excessive storage of iron after 
I 
might be the chief etiological factor of idiopathic hemo-
However, the experimental evidence supporting such a 
wv•~g~.uility is still lacking. The purpose of this investigation has 
to study the late morphological chahges of organs of non-anemic 
I 
anemic rabbits after prolonged intravenous administration of 
I 
I 
accharated iron oxide and to see whether prolonged administration of 
of the iron will result in hemochromatosis. 
A total of 103 young male rabbits and 9 young female rabbits weigh-
3.5 to 5-0 kg., kept in individual c~ages and all fed with ordinary 
bit pellets, carrots, green vegetables and water ad libitum, were 
The first grou~ consisted of 58 non-anemic 
! 
ts, 16 used as controls receiving n.o treatment and 42 treated with 
I 
d intravenous injections of saccharated iron oxide (Feojectin-
.. 
Kline and French Laboratories) with dosages gradually increasing 
20 to 200 mg. 'at intervals from 2 days to 2 months for a total 
od of 4 days to 14 months. The total dosages ranged from 45 to 
mg. of elemental iron per rabbit. The longer intervals of 
rabbits showing ~hlebothrombosis of the super-
1 veins that took time to recover so as to become available again 
The second group consisted of 54 anemic rabbits 
red anemic by repeated bleeding from ear veins with hemoglobin 
.[ 
intained below 6.0 gm. per 100 c.c. Seventeen of them were used for 
ontrols and 37 were injected with iron in a manner similar to that of 
1 e non-anemic injected rabbits for a pe~iod from 4 days to 12 months, 
l th a total corrected dosage of iron va&mg from 25 to 4040 mg. The 
d\sage was corrected for the iron lost t~ough bleeding by substraction 
\ i 
o\ 50 mg. of i~on for each 100 cc. of blood lost. The tissues of various 
o gans of both groups were fixed in 10 per cent neutral formalin and 
I 
t rn sectioned and prepared for microscopic examination with hematoxylin 
an, eosin stain and iron stain and aniline blue stains for liver in 
se ectad cases. The urines of rabbits having received a total of more 
th n 3000 mg. of elemental iron and of the i compatible controls were 
I 
te 
1 
ed for sugar (Benedict qualitative method) and their bloods checked. 
fo . level of glucose (modified Folin-Wu me~hod) ~ 
I In the control group of non-anemic rabbits none of the organs 
exa lined were grossly remarkable or showed the presence of iron-staining 
mat rial microscopically. One rabbit, howe~er, was found to have portal 
fib with proliferation of bile ducts irl liver. In the iron-injected 
' of non-anemic rabbits, the spleen and liver of those having 
rece ved totally more than 1000 mg of elemental iron showed definite 
i 
darkrrown co~or and enlargement tip to twice the norma~ si•e and weight, 
The .ivers of 2 rabbits receiving a total dol'?age of 3560 and 4100 mg. 
. ( . 
of i pn respectively were brown, 
consistency grossly. 
I 
with irregular nodular surfaces and 
! 
The bone ma'rrow of most of the animals 
ng a total of more than 2000 mg of iron was also brown. 
Micro copically, the spleen of every injected:rabbit showed the heaviest 
amoun of iron-positive pigment, mainly in th~ phagocytes in the red 
pulp. The pigment first appeared as fine, dust-like granules, then 
\ 
lally increased in size with increasing amounts of injected iron up 
to ~rge irregular masses throughout the spleen except the Malpighian 
co ~scles. The connective-tissue cells in.the capsule and the 
tculae and the endothelial lining of the capillaries and sinusoids 
contained similar pigment toward the high dose of the injection. 
i . 
acellular pigment masses were also noteq in red pulp after the 
e has been clogged with pigment macrophages. The normal architecture 
spleen was always well preserved. Fibrosis was never observed. 
The iver of rabbits that received less than 200 mg. of iron showed fine 
ironipositive pigment granules in all the Ku[ffer cells. With the 
incr asing amount of iron injected, similar pigment granules gradually 
' 
appe red in parenchymal cells in the central, zones of lobules, then in 
I 
all 1 he parenchymal cells but still more in central zones, and finally 
ther were marked large pigment masses in parenchymal cells in the 
\ . 
peri heral and central zones and a lesser amount in the intermediate zones. 
At t l later stage with more iron injected the connective-tissue cells in 
I 
the ortal spaces and the endothelial cells of_central veins also showed 
iron ~ositive pigment granules, but the epithelial cells of the bile ducts 
I I did so. In additiOn to the hemosiderosis, 20 injected normal rabbits 
sho ~ in the portal spaces various degrees ~f fibrosis, with proliferation 
of r· roblasts and small amounts of scattered iron-positive granules. 
I 
The brmal architecture of the liver was dis~orted but much less then 
that ln the few control rabbits with cirrhosise L~ss pigment was noted 
i 
in ma!rophages in the reticular stroma of bone marrow of every injected 
I . • 
sinuses and in connective-tissue c1,ells of capsules of the 
lymph nodes of approximately two thirds of the injected rabbits 
and l. macr~qages within the alveoli and in the endothelial lining of 
the bapillaries and larger blood vessels of!the lung in all the rabbits 
I 
\ . • I 
tha 
1 
received a total of more than 150 mg. qf iron. The adrenal glands 
sh ~d the pigment in reticular stroma cell~ of the cortex and the 
I : 
mad ·lary sinuses of all the injected rabbits. The kidney presented 
mode'ate amounts of fine granules of the pigment in glomerular tufts 
! 
and ubular epithelium of the ascending limb of Henlets loops and collect-
ing. ubules. The pituitary and parathyroid both showed small pigment 
gran les in their stroma cells in rabbits haying received comparatively 
I l larg doses of iron. The skin showed pigment in the hair follicles and 
of some rabbitsE;that received more than 700 mg. of iron. cori \ 
; I 
The 
amou t of pigment identified in ovary, testes, pancreas, thyroid, heart 
. i 
I 1 
and astrointestinal tract was small and usually in rabbits that received 
more 
gros 
Fibrosis of the pancreas was not noted in any rabbit. 
control group of the anemic rabbit~ none of the organs were 
y remarkable except the liver of one r~bbit, which showed slight 
·I 
nodu arity and increase of consistency. Microscopically, none of the 
examined contained iron-staining matertal. Two rabbits showed 
portal fibrosis, with proliferation of bile ducts and interruption 
II 
al hepatic architecture. In the iron!injected group of anemic 
rabbi s the findings were similar to those of the iron-injected normal 
rabbi s, with no apparent qualitative difference• However, none disclosed 
gross nodularity of the liver. Microscopically, 8 rabbits also showed in 
the p rtal spaces various degrees of fibrosis with proliferation of bile 
ducts land small amounts of scattered iron-positive pigment granules. . 
lood 
I 
I 
I 
sugar levels of the rabbits having received more than 3000 mg. 
~ 
77 
iron were in the same range as those of normal control rabbits. 
I 
i lycosuria was never demonstrated in any of the experimental animals tested. 
This investigation was able to demohstrate the pattern of progressive 
i . 
ron-overloading - loading of iron in the reticuloendothelial system during 
I ' 
I ' 
the early stage followed by loading to ~esser degrees in parenchymal 
1 . 
tissue during later courses of iron injection. Storage of iron in the 
~o major tissues, especially in the reticuloendothelial system Qf the 
i 
liver, spleen and bone marrow, is stressed. 
This investigation offers suggestive evidence that prolonged, 
intense administration of iron may result in progress from hemosiderosis 
to pigment fibrosis. The higher inci~ence and the milder degree of portal 
!fibrosis in experimental rabbits than in incidental cirrhosis of control 
:!rabbits and the scanty pigment in the i~creased portal fibrous tissue of 
/experimental animals suggest that the pbrtal fibrosis is not pre-existing. 
I 
lThis portal fibrosis was in ail cases arsociated with intense deposits of 
iron pigment in the peripheral zones of
1 
the hepatic lobule. The hypotheses 
I 
·advanced by various authors regarding the hemosiderosis progressing to 
: 
/pigment cirrhosis are discussed. There, was no clear evidence relating 
:the occurrence of fibrosis to either the total amount of iron administered 
' 
! or the duration of the iron deposit. The failure of previous animal 
l 
1experiments to produce hepatic fibrosi~ by overloading of iron is probably 
I 
I due either to insufficient amount of iron as evidenced by the largest 
total iron dose of 1025 per kilogram of body weight in this investigation 
i in comparison to 550 mg in the literature or the rate of administration 
/ may have been too slow. The largest total dose of 4.1 gm. ·f~r a rabbit 
I weighing 4.0 kg. in this investigation 1 is comparable to 72 gm. of iron 
i a human body weighing 70 kg. and is equivalent to 288 transfusions of 
b ood to a human body. 
In this investigation the anemia caused by bleeding did not appear to 
I 
f ~or the development of hepatic fibrosis. This may be explained on the 
. I 
! 
b sis of correction of the anemia withih ~ short time by iron injections 
a .d the consequent lack of prolonged tissue anoxia and lecal nutritional 
d !fici t for initiation of. the hepatic fibrosis if tissue anoxia does 
i 
itiate the damaging effect of iron pigment. 
I 
In conclusion, this investigation has demonstrated that 8 of the 37 
' i on-injected anemic rabbits and 20 of the 42 iron-injected non-anemic 
r bbits showed various degrees of portal fibrosis in the liver. Also 
gjven in the presentation ~sa comprehensive review of the literature 
o : iron metabolism, exogenous hemochromatbsis and idiopathic hemo:-
1 
c 1romatosis. 
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